Peter Chen1, Mile Stanojcic1, Marc G Jeschke2. 1. Sunnybrook Research Institute, Toronto, Ontario, Canada. 2. Sunnybrook Research Institute, Toronto, Ontario, Canada; Division of Plastic Surgery Department of Surgery, University of Toronto, Toronto, Ontario, Canada; Ross Tilley Burn Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. Electronic address: marc.jeschke@sunnybrook.ca.
Abstract
BACKGROUND: During the past decades' sepsis has become the major cause of death in severely burned patients. Despite the importance of burn sepsis, its diagnosis, let alone its prediction, is difficult if not impossible. Recently, we have demonstrated burn patients have increased NLRP3 inflammasome activation in white adipose tissue. We aimed to delineate a unique immune profile that can be used to identify septic outcomes in severely burned patients. METHODS: Adult burn patients (n = 37) admitted to our burn center between June 2013-2015 were enrolled in this study. White adipose tissue from the site of injury and plasma were collected from severely burned patients (>20% total body surface area) within 96 hours after thermal injury, indiscriminate of sex or age. RESULTS: We found that patients exhibiting aberrantly high levels of proinflammatory interleukin-1β and decreased macrophages at the site of injury are highly susceptible to development of sepsis. Septic patients also had increased anti-inflammatory (interleukin-10, interleukin-1RA) cytokines in plasma. The Septic Predictor Index was generated as a quotient for the site of injury macrophage proportion and interleukin-1β production. All patients who eventually develop sepsis had septic predictor index values >0.5. Septic patients with Septic Predictor Index values >1 all had sepsis onset within 12 days post-injury, whereas patients with Septic Predictor Index values between 0.5-1 all had later onset (>12 days). CONCLUSION: The Septic Predictor Index can determine sepsis onset accurately in thermally injured patients a priori and further enables surgeons to develop clinical studies and focused therapies specifically designed for septic cohorts.
BACKGROUND: During the past decades' sepsis has become the major cause of death in severely burned patients. Despite the importance of burn sepsis, its diagnosis, let alone its prediction, is difficult if not impossible. Recently, we have demonstrated burn patients have increased NLRP3 inflammasome activation in white adipose tissue. We aimed to delineate a unique immune profile that can be used to identify septic outcomes in severely burned patients. METHODS: Adult burn patients (n = 37) admitted to our burn center between June 2013-2015 were enrolled in this study. White adipose tissue from the site of injury and plasma were collected from severely burned patients (>20% total body surface area) within 96 hours after thermal injury, indiscriminate of sex or age. RESULTS: We found that patients exhibiting aberrantly high levels of proinflammatory interleukin-1β and decreased macrophages at the site of injury are highly susceptible to development of sepsis. Septic patients also had increased anti-inflammatory (interleukin-10, interleukin-1RA) cytokines in plasma. The Septic Predictor Index was generated as a quotient for the site of injury macrophage proportion and interleukin-1β production. All patients who eventually develop sepsis had septic predictor index values >0.5. Septic patients with Septic Predictor Index values >1 all had sepsis onset within 12 days post-injury, whereas patients with Septic Predictor Index values between 0.5-1 all had later onset (>12 days). CONCLUSION: The Septic Predictor Index can determine sepsis onset accurately in thermally injured patients a priori and further enables surgeons to develop clinical studies and focused therapies specifically designed for septic cohorts.
Authors: Jay S Fine; Alberto Rojas-Triana; James V Jackson; Laura W Engstrom; Gregory S Deno; Daniel J Lundell; Loretta A Bober Journal: Inflammation Date: 2003-08 Impact factor: 4.092
Authors: S O Heard; M P Fink; R L Gamelli; J S Solomkin; M Joshi; A L Trask; T C Fabian; L D Hudson; K B Gerold; E D Logan Journal: Crit Care Med Date: 1998-04 Impact factor: 7.598
Authors: Gerd G Gauglitz; Felicia N Williams; David N Herndon; Marc G Jeschke Journal: Curr Opin Clin Nutr Metab Care Date: 2011-03 Impact factor: 4.294
Authors: Mile Stanojcic; Peter Chen; Rachael A Harrison; Vivian Wang; Jeremy Antonyshyn; Juan Carlos Zúñiga-Pflücker; Marc G Jeschke Journal: Crit Care Med Date: 2014-06 Impact factor: 7.598
Authors: Marc G Jeschke; Celeste C Finnerty; Oscar E Suman; Gabriela Kulp; Ronald P Mlcak; David N Herndon Journal: Ann Surg Date: 2007-09 Impact factor: 12.969
Authors: Manish Kumar Saraf; David N Herndon; Craig Porter; Tracy Toliver-Kinsky; Ravi Radhakrishnan; Tony Chao; Maria Chondronikola; Labros S Sidossis Journal: J Burn Care Res Date: 2016 Mar-Apr Impact factor: 1.845
Authors: J G Cannon; R G Tompkins; J A Gelfand; H R Michie; G G Stanford; J W van der Meer; S Endres; G Lonnemann; J Corsetti; B Chernow Journal: J Infect Dis Date: 1990-01 Impact factor: 5.226
Authors: Marc G Jeschke; Margriet E van Baar; Mashkoor A Choudhry; Kevin K Chung; Nicole S Gibran; Sarvesh Logsetty Journal: Nat Rev Dis Primers Date: 2020-02-13 Impact factor: 52.329
Authors: Christian B Bergmann; Nadine Beckmann; Christen E Salyer; Marc Hanschen; Peter A Crisologo; Charles C Caldwell Journal: Front Immunol Date: 2021-02-25 Impact factor: 7.561